Sanara MedTech
SMTI
43 hedge funds and large institutions have $19.8M invested in Sanara MedTech in 2023 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 9 closing their positions.
0.52% less ownership
Funds ownership: 7.96% → 7.44% (-0.52%)
9% less funds holding
Funds holding: 47 → 43 (-4)
26% less capital invested
Capital invested by funds: $26.7M → $19.8M (-$6.97M)
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$341K |
| 2 |
BlackRock
New York
|
+$328K |
| 3 |
SIS
Strategic Investment Solutions
Orland Park,
Illinois
|
+$240K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$180K |
| 5 |
Lazard Asset Management
New York
|
+$97.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$590K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$319K |
| 3 |
Marshall Wace
London,
United Kingdom
|
-$234K |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
-$221K |
| 5 |
Rockefeller Capital Management
New York
|
-$221K |
SMTI Hedge Fund Activity: Q3 2023 in Review
43 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Sanara MedTech (SMTI) for Q3 2023, worth a combined $19.8M — down 26% from $26.7M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of SMTI and 5 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 11 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $341K. The largest seller was BAMCO Inc, exiting entirely with an estimated $590K sold.
- 43 institutional investors held Sanara MedTech (SMTI) as of Q3 2023, down from 47 in Q2 2023.
- Funds reported $19.8M of Sanara MedTech stock for Q3 2023, down 26% quarter-over-quarter.
- 5 funds opened new Sanara MedTech positions in Q3 2023 and 9 closed out, a net change of -4 holders.
- The largest Sanara MedTech buyer in Q3 2023 was Renaissance Technologies, an estimated $341K added.
- The largest Sanara MedTech seller in Q3 2023 was BAMCO Inc, an estimated $590K sold.
Based on aggregated 13F filings for Q3 2023.